American trypanosomiasis, Chagas disease, is a great cause of human morbidity and mortality in the Neotropics. Although there is currently no effective treatment for this parasitic disease, a number of potential biochemical targets have been identified, including the cysteine protease cruzain. Croton draco Cham. & Schldl. (Euphorbiaceae), commonly known as sangre de drago, is used in traditional medicine for a number of maladies. In this study, Croton draco bark essential oil has been shown to inhibit the activity of cruzain. The bark oil has been analyzed by GC-MS and the major components found to be β-caryophyllene (31.9%), caryophyllene oxide (22.0%), 1,8-cineole (6.2%), and α-humulene (5.6%). The major components have been tested for cruzain inhibitory activity, but show minimal activity, so it is not clear if the activity of Croton draco bark oil is due to a synergistic effect of the essential oil components or due to very active minor components. Croton draco bark oil has also been tested for cytotoxic activity against a panel of human tumor cell lines, but shows little activity.
TalaroK, TalaroA. (1993) Foundations in Microbiology. Wm. C. Brown Publishers, Dubuque, IA.
2.
CerecettoH, GonzalezM. (2002) Chemotherapy of Chagas’ disease: status and new developments. Current Topics in Medicinal Chemistry, 2, 1187–1213.
3.
ChanC, YinH, GarforthJ, McKieJH, JaouhariR, SpeersP, DouglasKT, RockPJ, YardleyV, CroftSL, FairlambAH. (1998) Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. Journal of Medicinal Chemistry, 41, 148–156.
4.
HajdukS, AdlerB, BertrandK, FearonK, HagerK, HancockK, HarrisM, Le BlancA, MooreR, PollardV, PriestJ, WoodZ. (1992) Molecular biology of African trypanosomes: development of new strategies to combat an old disease. American Journal of the Medical Sciences, 303, 258–270.
5.
CrossGAM. (2001) African trypanosomes in the 21st century: what is their future in science and health?International Journal of Parasitology, 31, 427–433.
6.
HarderA, GreifG, HaberkornA. (2001) Chemotherapeutic approaches to protozoa: kinetoplastida-current level of knowledge and outlook. Parasitology Research, 87, 778–780.
7.
SajidM, McKerrowJH. (2002) Cysteine proteases of parasitic organisms. Molecular and Biochemical Parasitology, 120, 1–21.
8.
McGrathME, EakinAE, EngelJC, McKerrowJH, CraikCS, FletterickRJ. (1995) The crystal structure of cruzain: a therapeutic target for Chagas’ disease. Journal of Molecular Biology, 247, 251–259.
9.
SetzerWN, SetzerMC. (2006) Antitrypanosomal agents from higher plants. In Biologically Active Natural Products for the Twenty-First Century.WilliamsLAD (Ed). Research Signpost, Trivandrum, India. 47–95.
10.
AnthonyJP, FyfeL, SmithH. (2005) Plant active components – a resource for antiparasitic agents?Trends in Parasitology, 21, 462–468.
11.
ValentinA, PélissierY, BenoitF, MarionC, KoneD, MallieM, BastideJM, BessièreJM. (1995) Composition and antimalarial activity in vitro of volatile components of Lippia multiflora.Phytochemistry, 40, 1439–1442.
12.
RosaMdSS, Mendonça-FilhoRR, BizzoHR, RodriguesIdA, SoaresRMA, Souto-PadrónT, AlvianoCS, LopesAHCS. (2003) Antileishmanial activity of a linalool-rich essential oil from Croton cajucara.Antimicrobial Agents and Chemotherapy, 47, 1895–1901.
13.
MoonT, WilkinsonJM, CavanaghHMA. (2006) Antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflata.Parasitology Research, 99, 722–726.
14.
MurilloRM, JakupovicJ, RiveraJ, CastroVH. (2001) Diterpenes and other constituents from Croton draco (Euphorbiaceae). Revista Biologica Tropical, 49, 259–264.
15.
YasunakaK, AbeF, NagayamaA, OkabeH, Lozada-PérezL, López-VillafrancoE, MuñizEE, AguilarA, Reyes-ChilpaR. (2005) Antibacterial activity of crude extracts from Mexican medicinal plants and purified coumarins and xanthones. Journal of Ethnopharmacology, 97, 293–299.
16.
ColvardMD, CordellGA, VillalobosR, SanchoG, SoejartoDD, PestleW, EcheverriTL, PerkowitzKM, MichelJ. (2006) Survey of medical ethnobotanicals for dental and oral medicine conditions and pathologies. Journal of Ethnopharmacology, 107, 134–142.
17.
Rodriguez-HahnL, RodriguezJJ, RomoA. (1975) Isolation and structure of draconin. Revista Latinoamericana de Química, 6, 123–124.
18.
HernándezJ, DelgadoG. (1992) Terpenoids from aerial parts of Croton draco.Fitoterapia, 63, 377–378.
19.
TsachevaI, RostanJ, IossifovaT, VoglerB, OdjakovaM, NavasH, KostovaI, KojouharovaM, KrausW. (2004) Complement inhibiting properties of dragon's blood from Croton draco.Zeitschrift für Naturforschung. Section C: Biosciences, 59, 528–532.
20.
MecciaG, RojasLB, RosqueteC, San FelicianoA. (2000) Essential oil of Croton ovalifolius Vahl from Venezuela. Flavour and Fragrance Journal, 15, 144–146.
21.
PalmeiraSF, MouraFdS, AlvesVdL, de OliveiraFM, BentoES, ConservaLM, AndradeHdA. (2004) Neutral components from hexane extracts of Croton sellowii.Flavour and Fragrance Journal, 19, 69–71.
22.
BoyomFF, KeumedjioF, DongmoPMJ, NgadjuiBT, ZolloPHA, MenutC, BessiereJM. (2002) Essential oils from Croton zambesicus Muell. Arg. growing in Cameroon. Flavour and Fragrance Journal, 17, 215–217.
23.
BlockS, FlaminiG, BrkicD, MorelliI, Quetin-LeclercqJ. (2006) Analysis of the essential oil from leaves of Croton zambesicus Muell. Arg. growing in Benin. Flavour and Fragrance Journal, 21, 222–224.
24.
RadulovićN, MananjarasoaE, HarinantenainaL, YoshinoriA. (2006) Essential oil composition of four Croton species from Madagascar and their chemotaxonomy. Biochemical Systematics and Ecology, 34, 648–653.
25.
SetzerWN. (2006) Chemical compositions of the bark essential oils of Croton monteverdensis and Croton niveus from Monteverde, Costa Rica. Natural Product Communications, 1, 567–572.
26.
LahlouS, Leal-CardosoJH, MagalhãesPJC, Coelho-de-SouzaAN, DuarteG. P. (1999) Cardiovascular effects of the essential oil of Croton nepetaefolius in rats: Role of the autonomic nervous system. Planta Medica, 65, 553–557.
27.
BakkaliF, AverbeckS, AverbeckD, ZhiriA, IdaomarM. (2005) Cytotoxicity and gene induction by some essential oils in the yeast Saccharomyces cerevisiae.Mutation Research, 585, 1–13.
28.
LikensST, NickersonGB. (1964) Detection of certain hop oil constituents in brewing products. American Society of Brewing Chemistry Proceedings, 2, 5–13.
29.
AdamsRP. (1995) Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy. Allured Publishing, Carol Stream, IL.
30.
EakinAE, McGrathME, McKerrowJH, FletterickRJ, CraikCS. (1993) Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi.Journal of Biological Chemistry, 268, 6115–6118.
31.
ReedLZ, MuenchH. (1938) A simple method of estimating fifty percent endpoints. American Journal of Hygiene, 27, 493–497.
32.
SetzerWN, SetzerMC, HopperAL, MoriarityDM, LehrmanG.K., NiekampKL, MorcombSM, BatesRB, McClureKJ, StessmanCC, HaberWA. (1998) The cytotoxic activity of a Salacia liana species from Monteverde, Costa Rica, is due to a high concentration of tingenone. Planta Medica, 64, 583.
33.
FerrariM, FornasieroMC, IsettaAM. (1990) MTT colorimetric assay for testing macrophage cytotoxic activity in vitro.Journal of Immunological Methods, 131, 165–172.
